| Literature DB >> 32600006 |
Seon-Kyung Park1, Hwi-Soo Seol2, Hee-Jin Park1, Yoon-Seob Kim1, Seung-Hun Ryu3, Jaehoon Kim3, Suejin Kim3, Jong-Hyeon Lee2, Jung-Hwan Kwon1.
Abstract
A mixture of 5-chloro-2-methylisothiazol-3(2H)-one/2-methylisothiazol-3(2H)-one (CMIT/MIT) had been used as an active ingredient in humidifier disinfectants (HDs). Owing to its high reactivity, the atmospheric concentration of CMIT/MIT, following its use in HD, would be lower than expected assuming that it is removed by ventilation only. In order to evaluate the exposure concentration of CMIT/MIT used as an HD, room-scale chamber studies were conducted under plausible use of three different HD doses at air change rates (ACR) of 0.3, 0.5, and 1.0 h-1. Atmospheric CMIT/MIT was sampled using two serial impingers containing deionized water after the attainment of steady state. Water samples in which CMIT/MIT was dissolved were concentrated using a cosolvent evaporation method with efficiencies of 35.5 and 77.9% for CMIT and MIT, respectively. The estimated air concentration, assuming that all the CMIT/MIT is absorbed in deionized water, increased linearly with increasing emission rate, but was independent of the ACR. This indicates that the removal rate of CMIT/MIT via chemical reactions is more than the removal rate by ventilation. Further investigations on homogeneous and heterogeneous chemical reactions of CMIT/MIT under ambient conditions are necessary to understand the actual exposure concentration of the mixture in HD.Entities:
Keywords: biocides; chemical reactions; chloromethyl/methyl-isothiazolinone (CMIT/MIT); health risk assessment; indoor air
Year: 2020 PMID: 32600006 PMCID: PMC7374189 DOI: 10.5620/eaht.e2020008
Source DB: PubMed Journal: Environ Anal Health Toxicol ISSN: 2671-9525
Figure 1Schematic diagram of the experimental chamber used in this study.
Experimental conditions
| Dose of HD | Initial concentration (mg L−1) | ACR (h−1) | t95, steady state (hr) | Sampling duration after initial emission (hr) |
|---|---|---|---|---|
| Recommended | CMIT: 0.81±0.05 | 0.3 | 10 | 13–15 |
| MIT: 0.29±0.01 | 0.5 | 6 | 9–11 | |
| 1.0 | 3 | 6–8 | ||
|
| ||||
| 5×recommended | CMIT: 3.74±0.13 | 0.3 | 10 | 13–15 |
| MIT: 1.25±0.04 | 0.5 | 6 | 9–11 | |
| 1.0 | 3 | 6–8 | ||
|
| ||||
| 10×recommended | CMIT: 7.25±0.68 | 0.3 | 10 | 13–15 |
| MIT: 2.55±0.12 | 0.5 | 6 | 9–11 | |
| 1.0 | 3 | 6–8 | ||
HD, humidifier disinfectants; ACR, air change rate; t95, steady state, Time required to attain the 95% steady-state atmospheric concentration.
Atmospheric concentration of 5-chloro-2-methyl-4-isothiazolin-3-one (CMIT) and 2-methyl-4-isothiazolin-3-one (MIT) estimated from theoretical calculations, assuming that they are conserved and the amount of CMIT and MIT measured using chamber studies
| Dose of HD | ACR (h−1) | Cair assuming conservative (μg m−3) | Cair estimated from measurements (μg m−3) | ||
|---|---|---|---|---|---|
|
|
| ||||
| MIT | CMIT | MIT | CMIT | ||
| Recommended | 0.3 | 7.40 | 20.78 | 0.40 | 0.95 |
| 0.5 | 4.21 | 11.77 | 0.33 | 0.74 | |
| 1.0 | 2.23 | 6.52 | 0.30 | 1.01 | |
|
| |||||
| 5×recommended | 0.3 | 34.27 | 102.08 | 1.04 | 3.10 |
| 0.5 | 20.39 | 60.47 | 1.43 | 4.41 | |
| 1.0 | 10.31 | 31.10 | 1.75 | 4.37 | |
|
| |||||
| 10×recommended | 0.3 | 68.94 | 200.78 | 3.31 | 14.12 |
| 0.5 | 41.18 | 118.77 | 3.96 | 14.79 | |
| 1.0 | 19.26 | 53.09 | 3.11 | 9.08 | |
HD, humidifier disinfectants; ACR, air change rate; Cair, atmospheric concentration.